Schedule 13G ownership disclosure

ADAMAS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00548A106

Event date: 2019-06-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,515,552
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-19-000346
Form type
SC 13G
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Jun 19, 2019
Reporting period
Jun 12, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub